• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

New terminology for cytoreduction in advanced ovarian cancer.

作者信息

Zapardiel Ignacio, Morrow C Paul

机构信息

Gynecologic Oncology Department, Santa Cristina University Hospital, Madrid, Spain.

出版信息

Lancet Oncol. 2011 Mar;12(3):214. doi: 10.1016/S1470-2045(10)70292-8.

DOI:10.1016/S1470-2045(10)70292-8
PMID:21376285
Abstract
摘要

相似文献

1
New terminology for cytoreduction in advanced ovarian cancer.晚期卵巢癌减瘤术的新术语
Lancet Oncol. 2011 Mar;12(3):214. doi: 10.1016/S1470-2045(10)70292-8.
2
Concept of optimal surgical cytoreduction in advanced ovarian cancer: a brief critique and a call for action.晚期卵巢癌最佳肿瘤细胞减灭术的概念：简要评论与行动呼吁
J Clin Oncol. 2007 Sep 20;25(27):4168-70. doi: 10.1200/JCO.2007.11.8992. Epub 2007 Aug 27.
3
A critique of surgical cytoreduction in advanced ovarian cancer.
Gynecol Oncol. 2000 Sep;78(3 Pt 1):269-74. doi: 10.1006/gyno.2000.5926.
4
[Towards a new standard in cytoreductive surgery for advanced ovarian cancer].
Bull Cancer. 2009 Dec;96(12):1175-82. doi: 10.1684/bdc.2009.0989.
5
Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer.复发性上皮性卵巢癌二次细胞减灭术后的围手术期发病率和结局。
Eur J Surg Oncol. 2010 Jun;36(6):583-8. doi: 10.1016/j.ejso.2010.04.012. Epub 2010 May 21.
6
Recent surgical management of ovarian cancer.卵巢癌的近期外科治疗
J Obstet Gynaecol Res. 2011 May;37(5):379-82. doi: 10.1111/j.1447-0756.2011.01569.x. Epub 2011 Apr 4.
7
Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: is there a case for thoracic cytoreduction?IV 期卵巢癌的腹盆腔细胞减灭术率和复发部位：是否有进行胸腹部细胞减灭术的适应证？
Gynecol Oncol. 2013 Oct;131(1):27-31. doi: 10.1016/j.ygyno.2013.07.093. Epub 2013 Jul 21.
8
[Role of intestinal resection in primary cytoreduction of ovarian cancer].
Minerva Ginecol. 2001 Feb;53(1 Suppl 1):100-1.
9
Splenectomy and surgical cytoreduction in epithelial ovarian cancer: a review.脾切除术和上皮性卵巢癌的手术细胞减灭术：综述。
Eur J Cancer Care (Engl). 2011 May;20(3):287-93. doi: 10.1111/j.1365-2354.2010.01224.x. Epub 2010 Sep 6.
10
Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study.完全细胞减灭术在晚期上皮性卵巢癌患者中是可行的且能使生存率最大化：一项前瞻性研究。
Gynecol Oncol. 1998 May;69(2):103-8. doi: 10.1006/gyno.1998.4955.

引用本文的文献

1
Prognostic Factors After the First Recurrence of Ovarian Cancer.卵巢癌首次复发后的预后因素
J Clin Med. 2025 Jan 13;14(2):470. doi: 10.3390/jcm14020470.
2
Prognostic factors in uterine adenosarcoma: subanalysis of the SARCUT study.子宫腺肉瘤的预后因素：SARCUT研究的亚分析
Front Oncol. 2024 May 21;14:1393707. doi: 10.3389/fonc.2024.1393707. eCollection 2024.
3
Prognostic Value of Lymph Node Ratio in Patients with Uterine Carcinosarcoma.淋巴结比值在子宫癌肉瘤患者中的预后价值
J Pers Med. 2024 Jan 30;14(2):155. doi: 10.3390/jpm14020155.
4
"Things Have Changed"-Laparoscopic Cytoreduction for Advanced and Recurrent Ovarian Cancer: The Experience of a Referral Center on 108 Patients.《世事变迁》——晚期及复发性卵巢癌的腹腔镜肿瘤细胞减灭术：一家转诊中心对108例患者的经验
Cancers (Basel). 2023 Dec 6;15(24):5726. doi: 10.3390/cancers15245726.
5
Impact of Hospital Case Volume on Uterine Sarcoma Prognosis: SARCUT Study Subanalysis.医院病例数量对子宫肉瘤预后的影响：SARCUT研究亚组分析
Ann Surg Oncol. 2023 Nov;30(12):7645-7652. doi: 10.1245/s10434-023-13826-4. Epub 2023 Jul 17.
6
Prognostic factors in undifferentiated uterine sarcoma: a subanalysis of the SARCUT study.未分化子宫肉瘤的预后因素：SARCUT 研究的亚组分析。
Arch Gynecol Obstet. 2023 Sep;308(3):981-988. doi: 10.1007/s00404-023-07057-x. Epub 2023 May 16.
7
Prediction of Surgical Outcome in Advanced Ovarian Cancer by Imaging and Laparoscopy: A Narrative Review.通过影像学和腹腔镜检查预测晚期卵巢癌的手术结果：一项叙述性综述
Cancers (Basel). 2023 Mar 22;15(6):1904. doi: 10.3390/cancers15061904.
8
Influence of Clinical and Surgical Factors on Uterine Carcinosarcoma Survival.临床及手术因素对子宫癌肉瘤生存率的影响
Cancers (Basel). 2023 Feb 25;15(5):1463. doi: 10.3390/cancers15051463.
9
Stage, treatment and survival of low-grade serous ovarian carcinoma in the Netherlands: A nationwide study.荷兰低级别浆液性卵巢癌的分期、治疗和生存情况：一项全国性研究。
Acta Obstet Gynecol Scand. 2023 Mar;102(3):246-256. doi: 10.1111/aogs.14518. Epub 2023 Feb 3.
10
Residual Disease Threshold After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 1: A Systematic Review and Network Meta-Analysis.原发性手术治疗晚期上皮性卵巢癌后残余病灶阈值：系统评价和网络荟萃分析。第一部分
Am J Ther. 2023;30(1):e36-e55. doi: 10.1097/MJT.0000000000001584. Epub 2022 Dec 20.